Effect of Phosphatidylserine on Cerebral Glucose Metabolism in Alzheimer's Disease
Effect Increase
Trial Design cohort
Trial Length 24weeks
Number of Subjects 8
Gender mixed
Notes for this study:
3 weeks supplementation of phosphatidylserine (source not stated, likely bovine cortex based) was able to increase global glucose utilization by 14.8% in the brains of persons with Alzheimer's relative to baseline; this was thought to underlie the benefits observed on symptoms of cognitive decline.